Drugs / umbilical cord mesenchymal stem cell conditioned media
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06688318 | Apr → Sep 2024 overdue | osteoarthritis, knee | National Research and Innovation Agency | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord mesenchymal stem cell conditioned media | “patients with knee joint OA who were given umbilical cord mesenchymal stem cell conditioned media via intra-articular injection.” NCT06688318 ↗ |
| Known as | secretome | “stem cells produce conditioned media (secretome, extra vesicles, and exosomes) that have tissue regeneration, immunomodulation, anti-inflammatory, and anti-apoptotic capabilities.” NCT06688318 ↗ |
| Modality | Other / unclassified | “conditioned media (secretome, extra vesicles, and exosomes)” NCT06688318 ↗ |